hPD-1/hCTLA-4

Nomenclature

C57BL/6Smoc-Pdcd1em1(hPDCD1)Ctla4em1(hCTLA4)Smoc

Cat. NO.

NM-HU-00079

Strain State

Embryo cryopreservation

Export PDF

Gene Summary

Gene Symbol
CTLA4

Gene Symbol
Pdcd1

Model Description

hPD-1(NM-HU-00015) was crossed with hCTLA4(NM-HU-00014)to generate hPD-1/hCTLA4 mice
Research Application:cancer research,Immunotherapy,drug screening

Validation Data

  PD-1 expression in stimulated T cells  


pd-1流式数据.png

10.png

Fig1. The expression of human PD-1 and CTLA-4 in double humanized PD-1&CTLA-4 mice was confirmed by FACS.

Efficacy studies

131.jpg

Fig2. In vivo validation of double humanized PD-1&CTLA-4 mice. Double humanized mice were inoculated with MC38 cells, and randomly assigned to different groups (n=8) when the tumor grew to a volume of 100 mm3. A combinatorial treatment of anti-CTLA-4 and anti-PD-1 demonstrated a noticeable efficacy improvement compared to the same dose of single agent (top) without affecting the animal body weight (Bottom).

Re-challenge studies

pd-1&ctla4 二次接种.jpg

Figure 3. As shown in the previous figure, animals of group 1-4 received different doses of either single agent or combinatorial treatment. This graph showed the progression of the tumor implanted in the cured, G4 mice, implicating a systematic anti-tumor effect induced by the combinatorial antibody treatment. 


You may also like

Shanghai Model Organisms Center Inc has licensed CRISPR-Cas9 technology from Broad Institute

On Dec 16, 2018, Broad Institute and Shanghai Model Organisms Center Inc (SMOC) has entered into a non-exclusive license agreement under which Broad has granted SMOC worldwide rights to commercialize a service platform for genetically modified mouse models under Broad's intellectual property.

Learn more
Milestones

Our vision is to provide researchers all over the world with comprehensive, convenient and professional animal model services to facilitate a simplified and highly-efficient approach towards uncovering the mysteries of life.

Learn more